Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

York Teaching Hospital Signs Up BD FocalPoint™

Published: Friday, September 13, 2013
Last Updated: Friday, September 13, 2013
Bookmark and Share
Fifth NHS cytology centre adopts Source BioScience’s automated screening technology.

Source BioScience has announced that, following a competitive tender process, York Teaching Hospital NHS Foundation Trust (‘York’) has renewed its contract for liquid based cytology (‘LBC’).

York has also committed to implementing Source BioScience’s automated cervical cancer screening BD FocalPoint™ technology.

The agreement is worth a total of £1.3 million over three years and was commenced on 1 April 2013.

Source BioScience provides customers with a unique and complete solution for cervical cancer screening, including HPV testing, from sample collection, processing, imaging and diagnostic testing.

The newest development in the screening process is BD FocalPoint™, the only automated technology for cervical cancer screening approved for use by the NHS, which is distributed in the UK by Source BioScience alone.

The BD FocalPoint™ technology is able to analyze and identify up to 25% of screening samples that can be reported as “No Further Review” (NFR) requiring no primary manual examination.

With over 3.9 million tests being undertaken across England and Wales during 2011-2012, the BD FocalPoint™ technology represents a significant reduction in laboratory workload and the need for additional staffing and outsourcing.

York Teaching Hospital is the fifth NHS cytology centre in England and Wales to adopt Source BioScience’s BD FocalPoint™ and the 7th platform to be placed within the NHS. This contract increases the aggregate value of the automated imaging business to Source BioScience to £0.6 million per annum over the next three years.

Trevor Hair, Head Biomedical Scientist for Cytology at York, said: “We’re delighted to have secured this contract on behalf of the Trust. In taking on additional cervical screening work from Hull and East Riding, our workload will increase from around 54,000 to 90,000 samples a year. The contract will make York laboratory the single cervical cytology screening provider for North and East Yorkshire and mean that all women who require a cervical screening test will now be able to have their samples examined at a single laboratory that will utilize the latest technology available in the UK.”

Dr Nick Ash, CEO at Source BioScience, commented: “Since the NHS published its implementation guidelines in July 2011, there has been significant interest from NHS Trusts in the BD FocalPoint™ technology. The renewal of the York contract and the adoption of the technology by another NHS Trust, demonstrates the determination to provide better timeliness and efficiencies for cervical cancer screening. This technology is an important growth driver for our business and we aim to win more contracts during 2013.”

During 2012, over two million women had their cervical cancer screening test undertaken using the technology provided by Source BioScience, which represents over 50% of all testing in England and Wales.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Source BioScience Launches New Overnight Service for DNA Sequencing
Overnight service offers free sample collection and rapid delivery of results in Scotland.
Monday, June 17, 2013
Source BioScience Announces Acquisition of Inverclyde Biologicals Limited
Acquisition of the entire issued share capital of Inverclyde for total consideration of £1.6 million.
Tuesday, April 30, 2013
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
Ovarian Cancer Insight
Study showed tumours release cytokines to attract macrophages, which secrete growth factors that in turn promote tumour growth.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Questioning the Safety of Selenium to Combat Cancer
Research indicates the need for change in practice as selenium supplements cannot be recommended for preventing colorectal cancer.
Supercomputers Could Improve Cancer Diagnostics
Researchers push the boundaries of cancer research through high-performance computing to map the human immunone.
Transgenomic, Precipio Diagnostics Merger
Merger will creates a robust diagnostic platform focused on improving accuracy of cancer diagnoses.
Leukaemia Cell Movement Gives Clues to Tackling Treatment-Resistant Disease
Researchers at Imperial College London have suggested that the act of moving itself may help the cells to survive, possibly through short-lived interactions with an array of our own cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos